Age-related eye diseases, their treatment, and the latest research to find cures will take center stage at the 2007 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting to be held at the Greater Fort Lauderdale/Broward County Convention Center in Fort Lauderdale, Fla., May 6-10, 2007.
People who have multiple sclerosis (MS) for 10 years and have few of the disabling symptoms of the disease are often told they have “benign MS” and that their symptoms will likely not ever occur to the same extent as other people with MS.
Every year, more than a thousand college students die by suicide, and thousands more attempt to kill themselves.
Chinese HIV/AIDS advocate and retired physician Gao Yaojie last week was put under house arrest by Chinese authorities to prevent her from visiting the U.S. next month to accept an award from the group Vital Voices Global Partnership.
Abul Hussam, an associate professor in the department of chemistry and biochemistry at George Mason University, Fairfax, Va., will receive the Grainger Challenge Gold Award of $1 million for his SONO filter, a household water treatment system.
Frost & Sullivan has awarded the COMPAS software technology platform its 2006 North America Technology Innovation of the Year Award in the field of Cardiac Safety Analytics.
Award-winning physician John Abramson argues that clinical trials provide no evidence of lowering cholesterol in women and elderly.
In a breakthrough that could make fuel cells practical for such small machines as lawnmowers and chainsaws, researchers have developed a new mechanism to efficiently control hydrogen fuel cell power.
On the morning of Friday, January 26, 2007, we invite you to celebrate with us a momentous event in the histories of Weill Cornell Medical College and the medical community of New York City. The presentation will include the opening of the new 13-story, 300,000-square-ft. Ambulatory Care and Medical Education Building along with the formal naming of the building.
Novartis announced that it has received a contract from the US Department of Health and Human Services (HHS) of approximately USD 55 million. The contract supports the company’s efforts to bring the antigen-sparing capabilities of the MF59 adjuvant to the United States. An adjuvant is a substance added to a vaccine to enhance the body’s immune response to the vaccine’s active constituent, called the antigen.